{14 (nirogacestat 150 MG Oral Tablet) } Pack

RxCUI: 2680369
RxNorm name: {14 (nirogacestat 150 MG Oral Tablet) } Pack
Display name: {14 (nirogacestat 150 MG Oral Tablet) } Pack
Full name: {14 (nirogacestat 150 MG Oral Tablet) } Pack
Term type: GPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OGSIVEO	NIROGACESTAT	SpringWorks Therapeutics, Inc.	f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	2026-03-26	Warnings, Adverse reactions	Exact identifier rxcui: 2680369

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	{14 (nirogacestat 150 MG Oral Tablet) } Pack	GPCK	14	These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023	20260326
f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	nirogacestat 150 MG Tablet 7-Day 14 Count Pack	PSN	14	These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023	20260326
f172e6ff-3190-41b0-b95a-58a7ef9e9e1e	nirogacestat 150 MG Tablet 7-Day 14 Count Pack	SY	14	These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023	20260326